SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Return
4.29%
This Quarter Return
+1.33%
1 Year Return
+4.29%
3 Year Return
+25.55%
5 Year Return
+55.64%
10 Year Return
–
AUM
$3.17B
AUM Growth
-$170M
(-5.1%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-6.3%
Top 10 Holdings %
Top 10 Hldgs %
37.05%
Holding
52
New
2
Increased
6
Reduced
38
Closed
1
Top Buys
| 1 |
FirstEnergy
FE
|
$556K |
| 2 |
NextEra Energy, Inc.
NEE
|
$492K |
| 3 |
Becton Dickinson
BDX
|
$340K |
| 4 |
KSU
Kansas City Southern
KSU
|
$327K |
| 5 |
Agilent Technologies
A
|
$232K |
Top Sells
| 1 |
DuPont de Nemours
DD
|
$15M |
| 2 |
Thermo Fisher Scientific
TMO
|
$14.6M |
| 3 |
Visa
V
|
$13.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$11.6M |
| 5 |
Merck
MRK
|
$10.7M |
Sector Composition
| 1 | Healthcare | 18.4% |
| 2 | Industrials | 13.8% |
| 3 | Energy | 11.64% |
| 4 | Technology | 11.37% |
| 5 | Utilities | 11.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Alphabet (Google) Class C
GOOG
$2.81T
| $86.2M | 2.72% |
3,104,633
-418,363
| -12% | -$11.6M |
|
27
Oracle
ORCL
$626B
| $85.3M | 2.69% |
2,085,668
-142,200
| -6% | -$5.82M |
|
28
Qualcomm
QCOM
$172B
| $83.8M | 2.65% |
1,063,237
-85,450
| -7% | -$6.74M |
|
|
CELG
29
DELISTED
Celgene Corp
CELG
| $69.4M | 2.19% |
993,856
-80,676
| -8% | -$5.63M |
|
30
Amgen
AMGN
$151B
| $40.2M | 1.27% |
326,098
-16,750
| -5% | -$2.07M |
|
31
Abbott
ABT
$231B
| $38.4M | 1.21% |
998,259
-91,404
| -8% | -$3.52M |
|
32
Mondelez International
MDLZ
$78.8B
| $10M | 0.32% |
290,750
-11,500
| -4% | -$397K |
|
|
TE
33
DELISTED
TECO ENERGY INC
TE
| $9.71M | 0.31% |
566,100
+3,900
| +0.7% | +$66.9K |
|
34
APA Corp
APA
$8.39B
| $5.21M | 0.16% |
62,750
+1,650
| +3% | +$137K |
|
35
Automatic Data Processing
ADP
$122B
| $3.98M | 0.13% |
58,659
-16,059
| -21% | -$1.09M |
|
|
36
FirstEnergy
FE
$25.1B
| $3.24M | 0.1% |
95,250
+16,350
| +21% | +$556K |
|
37
Union Pacific
UNP
$132B
| $2.9M | 0.09% |
30,900
-900
| -3% | -$84.4K |
|
38
Zimmer Biomet
ZBH
$20.8B
| $2.34M | 0.07% |
25,441
-206
| -0.8% | -$18.9K |
|
|
39
Agilent Technologies
A
$36.4B
| $2.17M | 0.07% |
54,173
+5,802
| +12% | +$232K |
|
40
Gilead Sciences
GILD
$140B
| $2.15M | 0.07% |
30,300
+1,900
| +7% | +$135K |
|
41
Bristol-Myers Squibb
BMY
$95B
| $1.54M | 0.05% |
29,700
-800
| -3% | -$41.6K |
|
42
Colgate-Palmolive
CL
$67.6B
| $1.13M | 0.04% |
17,400
-400
| -2% | -$26K |
|
43
UnitedHealth
UNH
$281B
| $1.04M | 0.03% |
12,700
| – | – |
|
44
Berkshire Hathaway Class B
BRK.B
$1.09T
| $937K | 0.03% |
7,500
| – | – |
|
|
45
Becton Dickinson
BDX
$54.8B
| $738K | 0.02% |
6,458
+2,973
| +85% | +$340K |
|
46
PepsiCo
PEP
$201B
| $610K | 0.02% |
7,300
-900
| -11% | -$75.2K |
|
47
Procter & Gamble
PG
$373B
| $609K | 0.02% |
7,550
| – | – |
|
|
48
NextEra Energy, Inc.
NEE
$146B
| $492K | 0.02% |
+20,600
| New | +$492K |
|
49
AbbVie
ABBV
$376B
| $437K | 0.01% |
8,500
| – | – |
|
|
KSU
50
DELISTED
Kansas City Southern
KSU
| $327K | 0.01% |
+3,200
| New | +$327K |
|